Atrial fibrillation trials recruiting in Minnesota

All Atrial fibrillation trials nationally

Cities in Minnesota

Recruiting trials in Minnesota

• A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
  NCT07227532 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: All (male and female) · Minnesota: Rochester
• A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
  NCT06455098 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Minnesota: Minneapolis
• Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
  NCT04045665 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Rochester
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
  NCT03907046 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Minneapolis, Saint Cloud, Saint Louis Park, Saint Paul
• BoxX-NoAF Clinical Trial
  NCT06989775 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · Minnesota: Rochester
• Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
  NCT06953726 · Phase: Phase 4 · Ages: 65 Years and older · Sex: All (male and female) · Minnesota: Minneapolis
• Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
  NCT07308847 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Minnesota: Minneapolis, Rochester
• Safety and Efficacy of the Sentinel Cerebral Protection Device in Atrial Fibrillation Ablation
  NCT04685317 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Rochester
• Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
  NCT07175428 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Maplewood
• Stellate Ganglion Block
  NCT06271707 · Phase: Phase 4 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Minnesota: Minneapolis
• The Fourth Left Atrial Appendage Occlusion Study
  NCT05963698 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Rochester
• The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
  NCT05836987 · Phase: Phase 3 · Ages: 22 Years to 85 Years · Sex: All (male and female) · Minnesota: Duluth, Minneapolis